Ternus Pharma, Inc. — Form D
Ternus Pharma, Inc. of DUXBURY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-10. The offering totals $1.0M, of which $185K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-11-10
- Form: D
- Accession: 0001688608-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $185K
- Remaining: $815K
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2016-10-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-274209
Issuer
- Name: Ternus Pharma, Inc.
- CIK: 0001688608
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 130 TOBEY GARDEN STREET, DUXBURY, MA, 02332
- Phone: 617-538-5688
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Marc R Cote | Director | Duxbury, MA |
| Sundeep R Dugar | Director | Duxbury, MA |
| William D Kerns | Director | Duxbury, MA |
| Dhiren D Thakker | Director | Duxbury, MA |
| Marc R Cote | Executive Officer | Duxbury, MA |
| Sundeep R Dugar | Executive Officer | Duxbury, MA |
| William D Kerns | Executive Officer | Duxbury, MA |
More